SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Semi-Equips - Buy when BLOOD is running in the streets! -- Ignore unavailable to you. Want to Upgrade?


To: studdog who wrote (9624)4/4/2001 11:59:22 PM
From: WTSherman  Read Replies (2) | Respond to of 10921
 
Well, the ones I have been looking at include CLTK($10 and change at today's close with $9.50 in cash, no debt and has been profitable the last couple of quarters), SRNA (which was down around $5.50 today has $3 in cash, no debt and has been consistently profitable for some time) and a speculative play which is NMGC that's selling under $3/sh with more than $4 in cash and no debt. What's interesting about NMGC is that they are totally refocusing the company away from their historic graphics business, literally wiping it out. It will be another 6-9 months before their new products go into production so there's little bad news between now and then. Among the semi equip's there IMSC which is about $10/sh and has almost $5.50 in cash. If you subtract the cash from the current share price you're left with a P/S ratio of about .6. That's pretty low for a company that's been making money and is pretty well positioned.

With the exception of NMGC the difference between these company's and COMS is that COMS has been losing a lot of money for some time so their cash position is not as strong as it looks. The litigation settlement hurt, too.

Of course, anything is possible in a bear market and stocks tend to get as oversold as they were overbought in the bubble. Nonetheless, I think that investing in company's that have a lot of cash and have shown strong growth over a number of years(like SRNA, IMSC) is worthwhile thinking about at these prices. Nibbling is where I'm at right now...